"Risk and Surrogate Benefit for Pediatric Phase I Oncology Trials"
Dr. Marcin Waligora will be speaking on "Risk and Surrogate Benefit for Pediatric Phase I Oncology Trials" on Wednesday, May 9, 2018, from 12 – 1 p.m. EDT.
An alum of Clarkson's NIH-funded Advanced Certificate Program in Research Ethics in Central and Eastern Europe, Dr. Waligora is currently a Fulbright Visiting Scholar at Harvard Medical School's Center for Bioethics. He is also an Associate Professor of Philosophy and Bioethics at Jagiellonian University Medical College in Krakow, Poland, where he heads up REMEDY (Research Ethics in Medicine Study Group), an interdisciplinary team of researchers dealing with ethical aspects of human subjects research.
Reserve Your Spot Today